Abbott Laboratories
Abbott Laboratories Announces Agreement to Acquire Exact Sciences for $21 Billion
Summary
On November 19, 2025, Abbott Laboratories announced the execution of a definitive Merger Agreement with Exact Sciences Corporation, a leader in cancer screening and precision oncology diagnostics. Under the terms, Abbott will acquire all outstanding shares of Exact Sciences for $105 per share in cash, totaling approximately $21 billion. The acquisition is expected to be immediately accretive to Abbott's revenue growth and gross margin. Abbott also entered into a commitment letter with Morgan Stanley Senior Funding, Inc. for up to $20 billion in senior unsecured bridge loans to finance the acquisition. The transaction is subject to customary closing conditions, including regulatory approvals and Exact Sciences shareholder approval, with a closing expected in the second quarter of 2026.
Profitelligence Alerts
Get alerts for ABT
Be first to know when Abbott Laboratories files with the SEC.
Filing Categories
Advertisement
About Abbott Laboratories
Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.
Official SEC Documents
Advertisement